zepbound - Search News

Eli Lilly cuts prices for Zepbound weight-loss drug

CNN on MSN · 2d

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

MarketWatch on MSN · 2d

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will also be adding two new doses,

Hosted on MSN · 2d

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

New obesity drugs are pushing the limit of how much weight is safe to lose

Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...

Lilly promotes ‘healthy skepticism’ toward compounded drugs in new Oscars ad campaign

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...

10h

Eli Lilly's big investment, cheaper Zepbound, and Hims & Hers' options: Pharma news roundup

Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...

Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results